BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiviral evaluation of 2',3'-dideoxy-2'-fluoro-3'- C-hydroxymethyl-beta-D-arabinofuranosyl pyrimidine nucleosides. 2003

Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Pharmasset Inc., Tucker, Georgia 30084, USA. ahassan@services.pharmasset.com

The synthesis and anti-HBV and anti-HIV activity of a number of 2',3'-dideoxy-2'-fluoro-3'-C-hydroxymethyl-beta-D-arabinofuranosyl pyrimidine nucleosides are reported.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Synthesis and antiviral evaluation of alpha-D-2',3'-didehydro-2',3'-dideoxy-3'-C-hydroxymethyl nucleosides.
January 2001, Nucleic acids research. Supplement (2001),
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Synthesis and antiviral evaluation of α-D-2',3'-didehydro-2',3'-dideoxy-3'-C-hydroxymethyl nucleosides.
October 2010, Bioorganic & medicinal chemistry letters,
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Synthesis and antiviral evaluation of 2',3'-dideoxy-2',3'-difluoro-D-arabinofuranosyl 2,6-disubstituted purine nucleosides.
January 2015, Heterocyclic communications,
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Synthesis and antiviral activity of purine 2',3'-dideoxy-2',3'-difluoro-D-arabinofuranosyl nucleosides.
May 2009, Nucleosides, nucleotides & nucleic acids,
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Fluoro carbocyclic nucleosides: synthesis and antiviral activity of 2'- and 6'-fluoro carbocyclic pyrimidine nucleosides including carbocyclic 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil and carbocyclic 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.
January 1990, Journal of medicinal chemistry,
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils.
January 1984, Journal of medicinal chemistry,
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Nucleosides. 133. Synthesis of 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)cytosines and related pyrimidine nucleosides as potential antiviral agents.
June 1985, Journal of medicinal chemistry,
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Rapid synthesis of 2',3'-dideoxy-3'β-fluoro-pyrimidine nucleosides from 2'-deoxypyrimidine nucleosides.
December 2010, Bioorganic chemistry,
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Synthesis of 2-fluoro-substituted and 2,6-modified purine 2',3'-dideoxy-2',3'-difluoro-d-arabinofuranosyl nucleosides from d-xylose.
March 2019, Tetrahedron,
Abdalla E A Hassan, and Balakrina S Pai, and Stefania Lostia, and Lieven Stuyver, and Michael J Otto, and Raymond F Schinazi, and Kyoichi A Watanabe
Synthesis of 2',3'-dideoxy-3'-C-(hydroxymethyl)-4'-thiopentofuranosyl nucleosides as potential antiviral agent.
April 1999, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!